Loading clinical trials...

Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1/2NCT02034071

Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome

• This is a single-center, open-label, single-arm study with a double-blind, placebo-controlled, randomized withdrawal extension. Patients are initiated on a DCCR dose of about 1.5 mg/kg (maximum star...

Lead sponsor: Essentialis, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Impact of Bright Light Therapy on Prader-Willi Syndrome

NCT05939453 · Prader-Willi Syndrome, Excessive Daytime Sleepiness, and more

RECRUITINGPhase 2

A Study of CSTI-500 in Patients With Prader-Willi Syndrome

NCT07348601 · Prader-Willi Syndrome

RECRUITING

Institutional Registry of Rare Diseases

NCT06573723 · Rare Diseases, Amyloidosis, and more

RECRUITINGPhase 1/2

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

NCT06239116 · Hypothalamic Obesity, Prader-Willi Syndrome, and more

RECRUITING

Register of Patients With Prader-Willi Syndrome

NCT02829684 · Prader-Willi Syndrome

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 1, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment13

Start dateApr 2014

Last updatedSep 1, 2016

Condition

Prader-Willi Syndrome

Locations shown

University of California, Irvine

Orange, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 1, 2016Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions